600713-80-2

Basic information

• Product Name: Benzoic acid, 5-methoxy-2-nitro-4-[(trifluoroacetyl)amino]-
• CAS NO: 600713-80-2
• Molecular Formula: C10H7F3N2O6
• Molecular Weight: 308.171
• Mol File: 600713-80-2.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 5-methoxy-2-nitro-4-[(trifluoroacetyl)amino]-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 5-methoxy-2-nitro-4-[(trifluoroacetyl)amino]-(600713-80-2)
• EPA Substance Registry System: Benzoic acid, 5-methoxy-2-nitro-4-[(trifluoroacetyl)amino]-(600713-80-2)

Safety Data

• Hazardous Substances Data: 600713-80-2(Hazardous Substances Data)

Upstream product

• 2486-69-3 3-methoxy-4-aminobenzoic acid 
• 212118-11-1 3-methoxy-4-(2,2,2-trifluoroacetamido)benzoic acid 

Downstream Products

• 600713-81-3 2,2,2-trifluoro-N-[4-(2-hydroxymethyl-pyrrolidine-1-carbonyl)-2-methoxy-5-nitro-phenyl]-acetamide 
• 1620874-85-2 2-chloro-3-hydroxy-4-(4-methylbenzoylamino)-6-nitrobenzoic acid ethyl ester 
• 1620874-86-3 7-chloro-5-nitro-2-(p-tolyl)benzoxazole-6-carboxylic acid ethyl ester 
• 1620874-87-4 5-amino-7-chloro-2-(p-tolyl)benzoxazole-6-carboxylic acid ethyl ester 
• 1620874-75-0 2-(5-amino-7-chloro-2-(p-tolyl)benzoxazol-6-yl)propan-2-ol 
• 1620874-88-5 4-benzoylamino-5-hydroxy-2-nitrobenzoic acid ethyl ester 
• 1620874-89-6 4-benzoylamino-2-chloro-3-hydroxy-6-nitrobenzoic acid ethyl ester 
• 1620874-90-9 7-chloro-5-nitro-2-phenylbenzoxazole-6-carboxylic acid ethyl ester 
• 1620874-91-0 5-amino-7-chloro-2-phenylbenzoxazole-6-carboxylic acid ethyl ester 
• 1620874-76-1 2-(5-amino-7-chloro-2-phenylbenzoxazol-6-yl)propan-2-ol 
• 1620874-92-1 4-amino-5-hydroxy-2-nitrobenzoic acid hydrochloride 
• 1620874-83-0 4-amino-5-hydroxy-2-nitrobenzoic acid ethyl ester 
• 1620874-84-1 5-hydroxy-4-(4-methylbenzoylamino)-2-nitrobenzoic acid ethyl ester 
• 600713-82-4 N-[5-amino-4-(2-hydroxymethyl-pyrrolidine-1-carbonyl)-2-methoxy-phenyl]-2,2,2-trifluoro-acetamide 

Relevant articles and documents

ALDEHYDE CONJUGATES AND USES THEREOF

The present invention provides compounds and methods of use thereof for the treatment, prevention, and/or reduction of a risk of a disease, disorder, or condition in which aldehyde toxicity is implicated in the pathogenesis, including ocular disorders, skin disorders, conditions associated with injurious effects from blister agents, and autoimmune, inflammatory, neurological and cardiovascular diseases by the use of a primary amine to scavenge toxic aldehydes, such as MDA and HNE.

NOVEL TRAPS IN THE TREATMENT OF MACULAR DEGENERATION

The present invention is directed to compounds of formula (A): pharmaceutical compositions, and methods of use for treating, reducing a symptom of or reducing the risk of macular degeneration.